Effects of magnesium, zinc, and chromium supplementation in adults with metabolic syndrome

Effects of magnesium, zinc, and chromium supplementation on components of metabolic syndrome in adults with metabolic syndrome: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0001552

Enrollment

Registered

2015-07-02

Start date

2014-05-27

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : 1) mineral sumpplementation - Magnesium oxide (Mg-TMC Plus) 300mg/day - Chromium(III) chloride (Cr-TGT FO) 600mcg/day - Zinc oxide (Zn-TZA Plus) 36mg/day 2)placebo: tablets a

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Study participants is adults aged 20-70 years who met the revised National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATP III) criteria for metabolic syndrome

Exclusion criteria

Exclusion criteria: - who took Mg, Zn, Cr supplements in the preceding 3 months, - who measured elevated liver enzyme levels (ALT > 129 IU/L), - who measured abnormal renal function(Creatinine > 1.5 mg/dL), - who had unstable hypertension, arrhythmia or a coronary heart disease event or hospitalization due to coronary heart disease in the preceding 6 months, - who suffered chronic obstructive pulmonary disease,or neuromuscular diseases, - who suffered substance abuse, or an unstable psychiatric condition, - who is pregnancy or in lactation.

Design outcomes

Primary

Measure	Time frame
improvement of metabolic syndrome components inbetween supplements group and placebo control group	—

Secondary

Measure	Time frame
association between hair mineral analysis and change of metabolic syndrome components	—

Countries

Korea, Republic of

Contacts

Public ContactHa-Na Kim

The Catholic University of Korea, St. Vincent's Hospital

onef01@naver.com+82-31-249-8246

Outcome results